| Stage | LEN | % of rev | IBP | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $8.0B | 100.00% | $808M | 100.00% | LEN ×9.95 |
| Gross profit | $619M | 7.69% | $257M | 31.84% | IBP +24.2pp |
| Operating income | $460M | 5.71% | $92M | 11.34% | IBP +5.6pp |
| Pre-tax income | $387M | 4.81% | $81M | 10.04% | IBP +5.2pp |
| Net income | $285M | 3.55% | $59M | 7.35% | IBP +3.8pp |
| Stage | LEN | IBP | Gap · A − B |
|---|---|---|---|
| Revenue | $8.0B100.00% | $808M100.00% | LEN ×9.95 |
| Gross profit | 7.69%$619M | 31.84%$257M | IBP +24.2pp |
| Operating income | 5.71%$460M | 11.34%$92M | IBP +5.6pp |
| Pre-tax income | 4.81%$387M | 10.04%$81M | IBP +5.2pp |
| Net income |
| 3.55%$285M |
| 7.35%$59M |
| IBP +3.8pp |
No shared counterparties.